Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.


2024-11-12	-99	-106
2024-08-12	-64	-50
2024-05-13	-308	-387
2024-03-28	-147	-405
2023-11-09	-549	-600
2023-08-10	-300	-550
2023-05-11	-450	-500
2023-03-09	-850	-550
2022-11-14	-600	-1.2 K
2022-08-15	-4.85 K	-112
2022-05-12	-5.75 K	-113
2022-03-14	-6.55 K	-116
2021-11-10	-10.05 K	-8.75 K
2021-08-12	-12.9 K	-7.65 K
2021-05-17	-8.25 K	-6.1 K
2021-03-10	-8.85 K	0
2020-11-12	-13.99 K	-15.73 K
2020-08-12	-13.99 K	-20.98 K
2020-05-07	-26.22 K	-27.97 K
2020-03-12	-33.22 K	-36.71 K
2019-11-12	-38.46 K	-38.46 K
2019-08-08	-38.46 K	-43.71 K
2019-05-09	-64.69 K	-38.46 K
2019-03-14	-38.46 K	-34.97 K
2018-11-08	-33.22 K	-23
2018-08-09	-2.73 K	-805
2018-05-09	-13.99 K	0
2018-03-12	-33.6 K	0
2017-11-10	-61.19 K	-43.71 K
2017-08-14	-52.45 K	-5
2017-05-16	-52.45 K	0
2017-04-03	-1.23 K	-525
2016-11-14	-34.97 K	-26.22 K
2016-08-15	-34.97 K	-26.22 K
2016-06-27	-43.71 K	-5
2016-02-16	-34.97 K	-34.97 K
2015-11-16	263	-43.71 K
2015-08-14	-875	-1.4 K
2015-06-29	175	-350
2015-03-15	-1.05 K	-1.05 K
2014-11-15	-875	-525
2014-06-30	-39.33 K	0
2014-03-31	-8.35 K	0
2013-12-31	-4.63 K	0
2013-09-30	-933.02	0
2013-06-30	-887.3	0

Helius Medical Technologies, Inc.

HSDT | NASDAQ Capital Market